
18.85 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 14.86 Today|||52-Week Range 24.65 | -3.68% Year-to-Date |
Better Gene Editing Stock: Intellia Therapeutics vs. Rocket Pharmaceuticals Sep 23 / MotleyFool.com - Paid Partner Content |
Previous close | 19.45 |
Today’s open | 19.19 |
Day’s range | 18.81 - 19.58 |
Volume | 66,753 |
Average volume (3 months) | 1,038,635 |
Market cap | $1.8B |
Earnings growth (last year) | -21.77% |
Earnings growth (this year) | +4.50% |
Earnings growth (next 5 years) | +30.28% |
Revenue growth (last year) | -- |
P/E ratio | NM |
Price/Sales | -- |
Price/Book | 3.31 |
Next reporting date | November 8, 2023 |
EPS forecast (this quarter) | -$0.80 |
Annual revenue (last year) | $0.00 |
Annual profit (last year) | -$221.9M |
Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cranbury, New Jersey |